T
TELO
Telomir Pharms
1.190
+0.030+2.59%After Hours: 1.190 0.000 0.00%19:30 09/08 EDT
OPEN/PREV CLOSE1.140/1.160
TODAY RANGE1.130-1.230
VOL74.91K
MARKET CAP81.84M
52 WEEK RANGE0.8885-2.091
AVG VOL (3M)95.82K
% TURNOVER0.11%
TURNOVER--
P/E (TTM)-1.3068
% RANGE8.61%
EPS(TTM)-0.9106
P/E(FORWARD)-3.1316
P/B16.26
BVPS0.0732
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP44.19M
SHARES OUTSTANDING68.77M
NEXT EARNINGS11/09-11/13
FREE FLOAT37.14M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/10 12:38
Telomir-Zn Preclinical Data Support Advancement in TNBC
Benzinga·08/04 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga·07/21 17:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·07/17 21:05
12 Health Care Stocks Moving In Friday's After-Market Session
TipRanks·06/15 12:37
Telomir Showcases Preclinical Telomir-Zn Diabetes Efficacy Data
TipRanks·06/15 12:34
Telomir Pharmaceuticals announces publication of data on Telomir-Zn
TipRanks·06/08 22:43
Telomir Pharmaceuticals Appoints Fractional CFO After Leadership Change
TipRanks·05/20 12:29
Telomir-Zn Preclinical Data Published in Wilson’s Disease
TipRanks·05/20 12:16
Telomir Pharmaceuticals reports peer-reviewed publication of data on Telomir-Zn
TipRanks·04/30 15:55
Telomir announces U.S. FDA cleared IND application for Telomir-Zn
TipRanks·04/30 13:44
Telomir Pharmaceuticals Receives FDA IND Clearance for Telomir-Zn
Benzinga·04/30 11:46
EXCLUSIVE: Telomir Pharmaceuticals Secures FDA Nod For Its Breast Cancer Therapy To Advance Into Human Study
TipRanks·04/24 13:34
Telomir Pharmaceuticals Completes TELI Acquisition, Expands Telomir-1 Rights
Same Industry
Name/Symbol
Change%
Price